Dallas, TX
December 14, 2009, 08:00 EST
Dr. Joe Duarte's Market I.Q.


The Internet's Intelligence Digest
Intelligence, Market Timing, And Trading Strategy For Traders and Investors


Health Care Legislation Has Plenty Of Holes
What's Hot Today:
U.S. stock index futures were pointing to a higher open on Monday. 1100 on the S & P 500 is now important support.

Today's Economic Calendar:
  • 4-Week Bill Announcement 11:00 AM ET

  • 3-Month Bill Auction 11:30 AM ET

  • 6-Month Bill Auction 11:30 AM ET
News For Thought

Obama poll numbers crash and burn over weekend. According to Ramsussen Reports.com: "The Rasmussen Reports daily Presidential Tracking Poll for Sunday shows that 23% of the nation's voters Strongly Approve of the way that Barack Obama is performing his role as President. Forty-two percent (42%) Strongly Disapprove giving Obama a Presidential Approval Index rating of -19." The president's poll numbers fell over the weekend. The poll numbers are the result of averaging over three days, so at least one or two days in this survey include the potential impact of the Copenhagen Climate Conference, the acceptance of the Nobel Peace Prize, the increasing likelihood of the passage of health care reform, and the analysis of the "surge" in Afghanistan. Over the last few days, the president has tried to turn his attention to job creation as well. Yet, the focus seems to be on tax increases, and methods that have yet to be shown to be effective, such as Small Business Administration loans, and the proposed use of TARP money for jobs.

Here's what's more telling about the potential problems for the president, as he is losing support accross the board. According to Rasmussen: "The 23% who Strongly Approve matches the lowest level of enthusiasm yet recorded. Just 41% of Democrats Strongly Approve while 69% of Republicans Strongly Disapprove. Among voters not affiliated with either major party, 21% Strongly Approve and 49% Strongly Disapprove." In other words, he has not lost the independents and is starting to lose his base.

Other subsectors of the poll are also alarming as "Among those who consider the economy to be the most important issue, just 26% Strongly Approve of the President’s performance while 39% Strongly Disapprove." And this one may be the kicker, as the president looks to spend more money and Congress is planning to raise the debt ceiling yet again. "Among those who consider fiscal policy issues the most important, just 1% Strongly Approve and 81% Strongly Disapprove."

What separates Rasmussen's numbers from the rest of the pack is that they are the views of likely voters, and that they are usually ahead of the other pollsters in rooting out new trends. If this holds up, Mr. Obama's popularity seems to be in the early stages of moving to yet a new set of lower lows.

Greenspan goes to bat for the Fed. Alan Greenspan went to bat for the Fed on "Meet the Press." The former Federal Reserve Chairman, iconized as "The Maestro" by Bob Woodward, noted that he thought the Fed had done all that it could at this point and needs to start focusing on inflation. Greenspan is joining a growing chorus that is suggesting that the Federal Reserve needs to start raising interest rates. Mr. Greenspan, in our opinion, did a great job as Fed Chairman. Lots of people disagree with us. We do have one beef with him, though, as he was greatly influential in leading President Clinton and Congress to repeal the Glass-Steagall Act. In our opinion, by allowing traditional banks to engage in investment banking, the wall between Wall Street risk and systemic risk to the economy was demolished, likely accelerating the subprime mortgage crisis.

That's a big stain on Mr. Greenspan's resume, as far as we're concerned.

Health Care Legislation Has Plenty Of Holes
Wild And Woolly Times Lie Ahead After Health Care "Reform"
President Obama announced over the weekend that he expects a health care bill to be out of the Senate by Christmas day. Yet, even as he made the announcement, key senators are still waffling on their support, as cost estimates suggest that the bill will likely increase health care costs.

As the year winds down, the pressure on Congress to pass a health care bill is on the rise. Yet, the future of the bill remains up in the air, suggesting that more wheeling and dealing is likely. The problem is that wheeling and dealing is more likely to increase costs, either to the government or individuals.

So far, the bill has hinged on what to do about Medicare and abortion. The Democrats want to expand Medicare to those aged 55 to 64. That seems to solve the problem of access. The problem is that the cost is estimated to run to about $640 per month as a premium. That's not much less than some families pay now as part of their employer based insurance. And more important, often those targeted to become part of this group may be partially disabled or limited in their ability to function, meaning that $640 per month is nearly impossible to pay.

If you add pre-existing conditions to the asterisk list, it gets worse. According to The Washington Post, a program proposed by the Senate to subsidize preexisting conditions until 2014 could actually run out of money as early as 2011. The source is Richard S. Foster, chief actuary at the Centers for Medicare & Medicaid Services, in a Dec. 10 report. That means that Congress would have to find more money for the program and add to the deficit.

The problem is that the so called "high risk pool," those with pre-existing conditions may cost much more to insure than the amount that Congress has put into the program, which is $5 billion. And when that money runs out, the covered person would be responsible for the premium increases. In other words, folks may get temporary coverage for maybe a year or two and then be potentially left out in the cold. According to The Post: "The bill says that if the $5 billion proves inadequate, the secretary of Health and Human Services "shall make such adjustments as are necessary to eliminate such deficit." Could that include freezing enrollment? The bill doesn't say."

And there is more fine print. As the Washington Post reported: "Even if Congress increased funding for the high-risk pool, some people with preexisting conditions could continue to go without care or incur crushing expenses. To qualify for the pool, people would have to be uninsured for six months."

Now to the cost issue. According to Reuters: "U.S. healthcare spending would rise by about $234 billion over the next decade under the Senate Democrats' overhaul bill and some of the proposed savings might never be achieved, a U.S. agency said in a report released on Friday." And this isn't some obscure agency, this is the agency that runs Medicare, which means that they actually have cost data and fairly accurate models for cost prediction, since they actually pay the bills. Reuters added: "The report, written by Richard Foster, the chief actuary at the Centers for Medicare and Medicaid Services, said the increase in healthcare spending reflected the impact of millions of newly covered people seeking medical care."

Mr. Foster acknowledged that there was more "uncertainty" than usual with his calculations, noted that "the added demand for health services at first may be difficult to meet and could lead to price increases and a reluctance by providers to treat patients with low-reimbursement health coverage."

According to the report: "Democrats argued the $2.5 trillion U.S. healthcare system is fraught with wasteful spending and the savings from wellness programs and payment system reforms that would reward quality rather than quantity of treatments and services would be greater than estimated."

To be sure, this is a fair argument. Yet, what those who talk about waste in the system fail to acknowledge is that some of that waste is based on patients that are non-compliant with doctor recommendations about medications. There is also a good deal of untreated mental illness in the general population that adds to cost as depression and other conditions keep patients from actually making it to the doctor's office or follow directions after being discharged from the hospital. There are lots of other social issues such as family dynamics and drug and physical abuse that are not being addressed in the cost structure.

Add transportation, malingering and other intangibles to the issues, and you are likely to add more intangible costs to the equation that few in Congress and the bureaucracy can't start to fathom and you have a ridiculously intricate web to manage.

Conclusion

Neither Congress or the insurance industry will ever "manage" health care, because it is unmanageable. Health care is human behavior at its most basic and has a major psychological component that shapes it.

Illness isn't just of the body. It has a major mental component, which in many cases is the overlying issue on everything else. In our other life, that of a physician, we get to experience health care in the trenches.

Folks tell us the most personal details about why they feel the way they do. And lots of the time, their back pain, although often rooted in arthritis, is being made worse by life in general. And there is usually no cure for life.

The bottom line is that Congress and the insurance industry are trying to control the cost of health care that is being brought on by the world we live in. People smoke, drink, use drugs, and are very depressed about what their lives have become, either because of their own personal choices, the effects of external events, or both.

In other words, Congress is fighting a losing battle. They will never be able to control costs. The more they tighten the noose, the worse things will become as depression, anxiety, and chronic illnesses that are influenced by anguish will flourish. People that are anxious and depressed don't want to exercise or go to work. They want Xanax and Vicoden, painkillers and anti-anxiety agents.

Think of it this way. Illness is Chaotic by nature. Thus it is predictably unpredictable. People will improve or eventually get worse, that much is nearly certain. What is uncertain is what may happen if that Chaotic relationship is altered. By fiddling with Chaos, Congress is likely to push the health care system into Disorder.

Know when to sell and how to make money when the market falls. Get a detailed trading plan in your pocket. Read Dr. Duarte's All NEW Books "Market Timing For Dummies." and "Trading Futures For Dummies." The Trading Manuals for All Seasons. Also Available As Kindle Books.

 


Market Moves - Stock Of The Day
Healthcare SPDR ETF (NYSE: XLV) Flourishes Amid Bill Controversy
The Healthcare SPDR ETF (NYSE: XLV) is near a new high despite the seeming threat of profit losses ahead for the sector based on health care "reform."



Chart Courtesy of StockCharts.com


Either health care investors know something or those who are pushing the sector higher are getting the rally out of their system before whatever changes that are coming make their way into the system.

XLV is moving nicely higher, which suggests that investors are betting that whatever comes out of Congress will so watered down that it won't make much difference tocompany earnings. And if that's the case what do investors know?

It's hard to figure. But maybe it's that even this late in the game some senators are saying that they won't vote for the plan. Or maybe it's the thought that some 30 million new paying customers will be added to the potential profit rolls.

If it's the latter, then the price increases that the pharmaceutical companies have put in place, as well as the way that drug stores have passed them through to customers, even on generic drugs, signal what's likely to be in the future.

If that's the bottom line, then we can see where the new highs on XLV have come from, the expectations for even more profits ahead as more people pay even higher prices for prescription medicines and likely even for other services.

Technical Look at the Market
S & P Finished Week Above 1100 But Not By Much - SPY ETF Remains at 4-stars
The S & P 500 again failed to close too convincingly above 1100 on 12-11. This leaves the market in limbo. The volatility bands around the 20-day moving average haver shrunk significantly, though, suggesting that a big move is coming.

That means that traders have to choose between the positive seasonality of the Christmas holidays, or the political uncertainties of the moment. That's a tough call, which is why the market is going nowhere.

So the technical aspects of the market are increasingly important, and that's why the volatility bands are very important to keep an eye on.

The bottom line is that it pays to be careful.

Summary of Start Rating System

We are adapting our star based rating system to the S & P SPDR ETF (NYSE: SPY). In this section a 5-star rating for SPY is a signal that down side risk is very low and that the chances of a further rise in prices are greater than those of a fall. A 4-star rating Means that the risk is less attractive but that the odds of a rise in SPY still outweigh the risks of a fall.

A 3-stars rating on SPY suggests that the odds of a rise and a fall are even. 2-stars and 1-stars suggest that down side risk is on the rise.

In no way is this star rating system intended as a series of buy and sell recommendations. The system is intended as a guide to the general trend of the market and the S & P SPDR ETF.

Star ratings can change rapidly based on the market's action. Followers of the ratings should review them on a daily basis.

Star Ratings for S & P SPDR ETF (NYSE: SPY) - updated 12-8-09

S & P SPDR ETF (NYSE: SPY), 4 stars on 12-1-09 - closing price 110.84. Closing price on 12-11-09 111.11. Short term support is at 109.57. Resistance is at 111.74. A move above 111.74 would raise the rating to 5-stars. A move below 109 would drop the rating to 3-stars.




Chart Courtesy of StockCharts.com




Chart Courtesy of StockCharts.com

 

 


Other Subscriber Reports are located on the website (log in required). These
reports are updated on a weekly basis (or as conditions require) and are not emailed:

S&P Timing  /  Bond Timing /  Dollar Timing /  Energy Timing
Gold Timing /  Tech Timing /  Biotech Timing


© Copyright 1996-2009, Market Timing Strategies, Inc., All Rights Reserved.
  • Market IQ reports may not be redistributed without permission.
  • Joe-Duarte.com is independently operated and solely funded by subscriber fees. This web site and the content provided is meant for educational purposes only and is not a solicitation to buy or sell any securities or investments. All sources of information are believed to be accurate, or as otherwise stated. Dr. Duarte and the publishers, partners, and staff of Joe-Duarte.com have no financial interest in any of the sources used. For independent investment advice consult your financial advisor. The analysis and conclusions reached on Joe-Duarte.com are the sole property of Dr. Joe Duarte.